Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer

JAMA Surgery

Volumn 149, Issue 5, 2014, Pages 482-485

  Gall, Tamara M H ^a   Jacob, Jimmy ^a   Frampton, Adam E ^a   Krell, Jonathan ^a   Kyriakides, Charis ^a   Castellano, Leandro ^a   Stebbing, Justin ^a   Jiao, Long R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGED; ARTICLE; BILE LEAKAGE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CELL SPREADING; CELLULAR DISTRIBUTION; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; LENGTH OF STAY; LYMPH NODE METASTASIS; LYMPH NODE RATIO; NO TOUCH ISOLATION PANCREATICODUODENECTOMY; OPERATION DURATION; OPERATIVE BLOOD LOSS; OVERALL SURVIVAL; PANCREAS CANCER; PANCREATIC LEAK; PANCREATICODUODENECTOMY; PILOT STUDY; PORTAL VEIN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE;

CARCINOMA, PANCREATIC DUCTAL; CELL COUNT; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY;

EID: 84901361088     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2013.3643     Document Type: Article

References (34)

1. Poruk KE, FirpoMA, Adler DG, Mulvihill SJ. Screening for pancreatic cancer. Ann Surg. 2013;257(1):17-26.
2. Sommerville CA, Limongelli P, PaiM, et al. Survival analysis after pancreatic resection for ampullary and pancreatic head carcinoma. J Surg Oncol. 2009;100(8):651-656.
3. Barugola G, Falconi M, Bettini R, et al. The determinant factors of recurrence following resection for ductal pancreatic cancer. JOP. 2007;8(1)(suppl):132-140.
4. Neoptolemos JP, Stocken DD, Friess H, et al European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350(12):1200-1210. (Pubitemid 38339364)
5. Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection. Cancer Lett. 2007;253(2): 180-204.
6. Muller V, Stahmann N, Riethdorf S, et al. Circulating tumor cells in breast cancer. Clin Cancer Res. 2005;11(10):3678-3685.
7. Slade MJ, Payne R, Riethdorf S, et al. Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment. Br J Cancer. 2009;100(1):160-166.
8. Ren C, Han C, Zhang J, et al. Detection of apoptotic circulating tumor cells in advanced pancreatic cancer following 5-fluorouracil chemotherapy. Cancer Biol Ther. 2011;12(8):700-706.
9. de Albuquerque A, Kubisch I, Breier G, et al. Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients. Oncology. 2012;82(1):3-10.
10. Mudan S, Giakoustidis A, Thillainayagam AV, Jacob J, Stebbing J. Clinical utility of circulating tumor cell measurement in the diagnosis of indeterminate lesions of the pancreas. Future Oncol. 2010;6(1):177-179.
11. Kurihara T, Itoi T, Sofuni A, et al. Detection of circulating tumor cells in patients with pancreatic cancer. J Hepatobiliary Pancreat Surg. 2008;15(2):189-195. (Pubitemid 351516978)
12. Jiao LR, Apostolopoulos C, Jacob J, et al. Unique localization of circulating tumor cells in patients with hepatic metastases. J Clin Oncol. 2009;27(36):6160-6165.
13. Rahbari NN, Aigner M, Thorlund K, et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology. 2010;138(5):1714-1726.
14. Hirota M, Kanemitsu K, Takamori H, et al. Pancreatoduodenectomy using a no-touch isolation technique. Am J Surg. 2010;199(5):e65-e68.
15. Berger AC,Watson JC, Ross EA, Hoffman JP. Themetastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg. 2004;70(3):235-240.
16. Bitsakou G, Frampton AE, Pai M, Jiao LR. An alternative pancreatic anastomosis following pancreaticoduodenectomy. Arch Surg. 2011;146(6):752-754.
17. Wang R, Lagakos SW, Gray RJ. Testing and interval estimation for two-sample survival comparisons with small sample sizes and unequal censoring. Biostatistics. 2010;11(4):676-692.
18. Barnes JP. Physiologic resection of the right colon. Surg Gynecol Obstet. 1952;94(6):722-726.
19. Turnbull RB Jr, Kyle K,Watson FR, Spratt J. Cancer of the colon. Ann Surg. 1967;166(3):420-427.
20. Wiggers T, Jeekel J, Arends JW, et al. No-touch isolation technique in colon cancer. Br J Surg. 1988;75(5):409-415.
21. Kobayashi S, Asano T, Ochiai T. A proposal of no-touch isolation technique in pancreatoduodenectomy for periampullary carcinomas. Hepatogastroenterology. 2001;48(38):372-374. (Pubitemid 32391569)
22. Hirota M, Hashimoto D, Ishiko T, et al. Distal pancreatectomy using a no-touch isolation technique. Scand J Surg. 2012;101(3):156-159.
23. Hirota M, Shimada S, Yamamoto K, et al. Pancreatectomy using the no-touch isolation technique followed by extensive intraoperative peritoneal lavage to prevent cancer cell dissemination. JOP. 2005;6(2):143-151. (Pubitemid 41573818)
24. O'Flaherty JD, Gray S, Richard D, et al. Circulating tumour cells, their role inmetastasis and their clinical utility in lung cancer. Lung Cancer. 2012;76(1):19-25.
25. OnstenkW, Gratama JW, Foekens JA, Sleijfer S. Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics. Cancer Treat Rev. 2013;39(7): 691-700.
26. Schindlbeck C, Andergassen U, Hofmann S, et al. Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients. J Cancer Res Clin Oncol. 2013;139(6):1055-1062.
27. Munzone E, Botteri E, Sandri MT, et al. Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer. Clin Breast Cancer. 2012;12(5):340-346.
28. Gazzaniga P, Gradilone A, de Berardinis E, et al. Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer. Ann Oncol. 2012;23(9):2352-2356.
29. Naito T, Tanaka F, Ono A, et al. Prognostic impact of circulating tumor cells in patientswith small cell lung cancer. J Thorac Oncol. 2012;7(3):512-519.
30. Shamash J, Jacob J, Agrawal S, et al. Whole blood stem cell reinfusion and escalated dose melphalan in castration-resistant prostate cancer. Clin Cancer Res. 2012;18(8):2352-2359.
31. Bidard FC, Huguet F, Louvet C, et al. Circulating tumor cells in locally advanced pancreatic adenocarcinoma. Ann Oncol. 2013;24(8):2057-2061.
32. Negin BP, Meropol NJ, Alpaugh RK, et al. Characterization and prognostic significance of circulating tumor cells in the peripheral blood of patients with metastatic pancreatic cancer. J Clin Oncol. 2010;28(suppl):15s.
33. Tjensvoll K, Nordgard O, Smaaland R. Circulating tumor cells in pancreatic cancer patients. Int J Cancer. 2014;134(1):1-8.
34. Khoja L, Backen A, Sloane R, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106(3):508-516.